An injectable medicine for osteoporosis (and bone protection in cancer)
Denosumab
An injection given every six months for osteoporosis that strengthens bone and reduces fractures — effective, but its effect wears off if doses are missed, so it must be given on time.
What is Denosumab?
Denosumab is an injectable medicine for osteoporosis that reduces the risk of fractures by slowing the breakdown of bone. For osteoporosis it is given as an injection under the skin every six months (brand Prolia). Its effect reverses quickly if a dose is delayed or stopped — with a rebound rise in fracture risk — so doses must be given on time, and stopping is managed carefully. Calcium and vitamin D are usually taken alongside.
Education and reference only. This is a plain-language guide to Denosumab — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Denosumab is a targeted (monoclonal antibody) medicine that strengthens bone. In osteoporosis it is given as a small injection under the skin every six months to reduce the risk of fractures, and it is a valuable option for people who cannot take or tolerate bisphosphonates, or who have reduced kidney function. (A higher-dose version, under a different brand, is used to protect bones affected by some cancers.) It works differently from a tablet and is administered by a healthcare professional.
How it works
Bone is constantly being broken down and rebuilt. The cells that break bone down (osteoclasts) are activated by a signal called RANKL. Denosumab is an antibody that binds to RANKL and blocks it, so fewer osteoclasts form and less bone is broken down — allowing bone density to build up and the risk of fracture to fall. Because it only works while it is present in the body, its effect fades once a dose is overdue.
What it treats
Conditions Denosumab is used for
Practical use
How to take Denosumab
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- Attend every scheduled injection on time (every six months for osteoporosis) — do not let a dose lapse, as protection is lost and fracture risk can rebound.
- Take the calcium and vitamin D your team recommends, so your calcium level is adequate before each dose.
- Have a dental check-up before starting if advised, keep up good dental hygiene, and report jaw pain or slow-healing dental problems.
- Report symptoms of low calcium — tingling around the mouth or in the fingers, or muscle cramps and spasms.
- If the medicine is ever stopped, follow the plan for a follow-on bone medicine to prevent rebound bone loss.
Weighing it up
Advantages & disadvantages of Denosumab
Advantages
- Effectively reduces fractures in osteoporosis, with a convenient six-monthly injection.
- Can be used when bisphosphonates are unsuitable, including in reduced kidney function.
- No need for the specific dosing routine of oral bisphosphonates.
Disadvantages
- Effect reverses quickly if doses are missed, with a rebound risk of spinal fractures.
- Requires adequate calcium/vitamin D and attention to dental health.
- Given by injection rather than taken as a tablet.
Practical use
Good to know
The most important practical point is timing: denosumab’s bone-protecting effect wears off within months of a missed or stopped dose, and this can be followed by a rapid loss of bone density and, importantly, a raised risk of multiple spinal fractures ("rebound"). So injections must be given on schedule (every six months for osteoporosis), and if it is ever stopped, another bone medicine is usually given to protect against rebound. Calcium and vitamin D levels must be adequate before each dose (low calcium is a risk), so a supplement is usually taken. Good dental care matters, because rarely denosumab can affect the jaw bone (osteonecrosis of the jaw) — have a dental check before starting if advised, and report jaw pain or non-healing dental problems.
Who should not take it / use with caution
- People with a low blood calcium level, until it is corrected.
- People with unhealed dental or jaw problems (a dental review is arranged first if needed).
- Pregnancy and breastfeeding — it is avoided; women who could become pregnant use reliable contraception.
Monitoring
- Blood calcium (and vitamin D) before doses
- Dental health
- Bone density and fracture status; timely re-dosing
Side effects
- Common: joint or muscle aches, and an increased tendency to some infections (skin, urinary).
- Low blood calcium — report tingling, numbness or muscle cramps.
- Rarely: osteonecrosis of the jaw (jaw pain, non-healing dental sockets), unusual thigh-bone fractures, and — if stopped without cover — rebound spinal fractures.
Key interactions
- It has few conventional drug interactions.
- Other medicines that lower calcium add to the risk of low calcium.
- Combining with other bone or immune-suppressing treatments needs specialist coordination.
Available as: A pre-filled injection given under the skin by a healthcare professional (six-monthly for osteoporosis).
Answers
Denosumab: frequently asked questions
What happens if I miss a denosumab injection?
Denosumab’s protection wears off within months of a missed dose, and this can be followed by rapid bone loss and a raised risk of multiple spinal fractures. So it is important to have each injection on time (every six months for osteoporosis). If it is ever going to be stopped, your doctor will usually arrange another bone medicine to protect you against this "rebound".
Why do I need calcium and vitamin D with it?
Denosumab can lower your blood calcium, so your calcium and vitamin D need to be adequate before each dose — which is why a supplement is usually taken. Report symptoms of low calcium such as tingling around the mouth or in the fingers, or muscle cramps.
Should I see a dentist before starting?
If advised, yes — because denosumab can rarely affect the jaw bone (osteonecrosis of the jaw), a dental check-up before starting and good ongoing dental care reduce the risk. Report any jaw pain or dental problems that are slow to heal, and tell your dentist you are on denosumab.
How is it different from a bisphosphonate tablet?
Both reduce bone breakdown and fractures, but denosumab is a six-monthly injection that works in a different way, and it can be used when bisphosphonates are unsuitable (for example in reduced kidney function). A key difference is that denosumab’s effect reverses if stopped, so timing and a planned follow-on are more important than with bisphosphonates.
The wider class
About RANKL inhibitor (bone / osteoporosis)
Denosumab belongs to the rankl inhibitor (bone / osteoporosis) class. For how the class as a whole works, its shared safety principles and monitoring, see the full guide.
Browse by body system
Authoritative sources
- BNF: Denosumab.
- electronic Medicines Compendium (SmPC): Prolia; Xgeva.
- NICE TA204: Denosumab for the prevention of osteoporotic fractures.
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.